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Abstract  
 
Bipolar disorder (BD) is a chronic psychiatric illness characterized by fluctuation in mood state, 
with a relapsing and remitting course. Frontotemporal dementia (FTD) is a clinically and 
genetically heterogeneous syndrome, with the most frequent phenotype being behavioral variant 
frontotemporal dementia (bvFTD). Here, we report the case of an Italian male presenting with late 
onset bipolar disorder, that developed bvFTD over time, carrying a mutation in the GRN gene.  
Interestingly, the patient carried the c.1639 C>T variant in GRN gene, resulting in a R547C 
substitution. Our case report further corroborates the notion that, in addition to FTD, progranulin 
may be involved in the neurobiology of bipolar disorder type 1, and suggests to screen patients with 
late onset bipolar disorder for GRN mutations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction 
 
Bipolar disorder (BD) is a psychiatric illness characterized by fluctuation in mood state with a 
relapsing and remitting course. Genetic studies showed that BD is a complex disease, consisting of 
both common and rare susceptibility variants (1). Frontotemporal dementia (FTD) is a clinically 
heterogeneous syndrome. The most frequent phenotype is behavioral variant frontotemporal 
dementia (bvFTD), followed by semantic dementia, and progressive non-fluent aphasia. Three 
genes have been shown to be major causes of FTD: microtubule-associated protein tau (MAPT), 
progranulin (GRN), and C9ORF72 (2).  
Here we report the case of an Italian male presenting with late onset bipolar disorder, that developed 
bvFTD carrying the R547C mutation in GRN gene.  
 
 
Case Report 
 
A 70 years old man was diagnosed with bipolar disorder type 1 at 55 years of age. He reported 
depressive episodes when he reached his thirties. The onset of maniacal symptoms was at 54 years, 
when the patient presented elevated mood, impulsiveness, and grandiose delusion. The patient was 
hospitalized in a psychiatric ward and a diagnosis of BD type 1 was made. Thence, a combined 
therapy with escitalopram and carbolithium was introduced with improvement of psychiatric 
symptoms. At 67 years of age, the patient was newly hospitalized for acute lithium intoxication 
(plasmatic range 1,89 mEq/l) with severe hypernatriemia and ipokaliemia. At discharge, he did not 
show any signs of cognitive impairment and he had a complete recover.  
At 68 years, 15 years after the diagnosis of BD, the patient become less extrovert, and presented 
with indifference, and hyperphagia. The clinical picture progressively deteriorated and he became 
apathetic with lacking motivation, and retiring from social and leisure activities. The patient was 
admitted to our Aging Brain and Memory Clinic, Department of Neuroscience, University of 
Torino. Familial history revealed that the son was suffering by panic attacks, while the deceased 
mother and the maternal grandmother were affected by late onset unspecified dementia, suggesting 
an autosomal dominant inheritance. The neurological examination showed mild bilateral 
parkinsonian signs. The neuropsychological assessment revealed a mild cognitive impairment 
(MMSE was 22.4/30), deficit in selective attention, verbal memory, and executive dysfunction. 
Cranial CT evidenced asymmetrical brain ventricles and mild frontotemporal atrophy (Fig. 1A). 
CSF examination showed normal values of total Tau (152.6 pg/ml), posphorilated Tau (34.7 pg/ml), 
and Aβ-42 (805.6 pg/ml). Brain 18-FDG PET revealed marked hypometabolism in bilateral 
frontotemporal areas. A diagnosis of bvFTD was made according to Rascovsky et al. criteria (3).  
MAPT, GRN, C9ORF72 genes were sequenced and we did not detect neither mutations in MAPT 
nor expansions in C9ORF72.  Interestingly, the genetic analysis revealed the c.1639 C>T variant in 
GRN gene, in exon 12, resulting in a R547C substitution. We considered the variant as a pathogenic 
mutation since a) at least three of the four in silico tools predicted the variant as pathogenic 
(Polyphen2, GVGD and SNAP predicted the variant to be deleterious, whereas SIFT classified it as 
neutral); b) the variant affects a highly evolutionary conserved aminoacid (Fig. 1B); c) the change 
was absent in genetic databases (ExAc, dbSNPs, and 1000 Genomes).  
 
 
 
Discussion 
 
Our case report confirms previous studies suggesting an association between bipolar disorder type 1 
and progranulin mutations (4). In addition, we report the first association between BD type 1 and 
the genetic variant R547C, a mutation previously described in a bvFTD patient with parkinsonism 
and impulse control disorder (5). Due to the limitations of in silico prediction programs and the lack 
of additional family members to test for co-segregation, functional studies are suggested to further 
support the pathogenicity of the identified variant.  
 
Notably, GRN polymorphisms have been shown to contribute to the susceptibility to BD type 1, and 
progranulin plasma concentrations are lowered in patients with BD (6). Progranulin is a pleiotropic 
protein widely expressed in the nervous system both during development and adulthood. Little is 
known about the normal function of the protein in CNS, apart from a role in inflammation, long-
term neuronal survival, and neurodegeneration (7).   
 
Psychiatric symptoms have been reported as initial manifestations of bvFTD, in particular in the 
genetic forms due to an expansion in C9ORF72 (up to 50% of cases) (8), and to mutation in GRN 
(up to 25% of patients) (9). Our patient presented an affective disorder before the bvFTD diagnosis, 
and this may suggest that the BD might represent a preclinical phase preceding the onset of 
frontotemporal dementia. 
 
In conclusion, our case report further corroborates the notion that progranulin may also be involved 
in the neurobiology of bipolar disorder type 1, and suggests to screen late-onset patients for GRN 
mutations. 
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